ASGE Annual GI Advanced Practice Provider Course (Virtual) - Clinical Case-Based Learning (Day Two) | April 2023-Evaluation and Management of IBD

Video Transcription

Video Summary

In the video, Kimberly Kearns, a nurse practitioner specializing in adult gastroenterology, presents on the evaluation and management of inflammatory bowel disease (IBD). She provides an overview of IBD, including its subtypes (Crohn's disease and ulcerative colitis) and its prevalence and impact on the healthcare system. Kearns discusses the pathophysiology of IBD, which involves genetics, environmental factors, microbiome disruption, and immune dysregulation. She highlights the differentiating features between Crohn's disease and ulcerative colitis, including the areas of the gastrointestinal tract affected, inflammatory patterns, and clinical symptoms.<br /><br />Kearns then reviews various treatment options for IBD, including corticosteroids, aminosalicylates, immunomodulators, biologics, and small molecules. She explains the mechanism of action, dosing, monitoring, and potential side effects of each treatment. Kearns also emphasizes the importance of proactive and reactive therapeutic drug monitoring to optimize therapy and achieve treatment targets.<br /><br />The video concludes with a discussion on health disparities in IBD and the need for a deeper understanding of the role of race and ethnicity in patient care. Kearns encourages healthcare providers to expand their knowledge on health disparities and use inclusive language when referring to different racial and ethnic groups.<br /><br />Overall, the video provides a comprehensive overview of the evaluation and management of IBD, highlighting key points on differentiating features, treatment options, and health disparities.

Asset Subtitle

Kimberly Kearns, MS, APN-BC

Keywords

IBD

Crohn's disease

ulcerative colitis

treatment options

health disparities

therapeutic drug monitoring

pathophysiology

gastrointestinal tract